Amplifi Vascular, Inc.Amended
Biotechnology · Prairie Village, KS
BiotechnologySEC Form D
Amplifi Vascular, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 26, 2026, reporting $5,910,278 raised toward a $6,000,000 offering.
Incorporated in Delaware and based in Prairie Village, KS, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Amplifi Vascular, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Sean MorrisExecutive Officer · Director
- Nathaniel HagedornDirector
- James SchultzDirector
- Steve BraunDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised